Clinical Trial Update: Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb [Phase 2]

View source ↗

Summary

Phase 2 trial comparing R-COMP to R-CHOP in newly diagnosed non-localised DLBCL and Follicular Lymphoma Grade IIIb has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma Grade Iiib

Drugs mentioned

• R-CHOP
• R-COMP (not specified)

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Lymphoma | Phase 2 | Status: COMPLETED